Maspin, a non-inhibitory member of the serine protease inhibitor superfamily, has been characterized as a tumor suppressor gene in multiple cancer types. Among the established anti-tumor effects of Maspin are the inhibition of cancer cell invasion, attachment to extracellular matrices, increased sensitivity to apoptosis, and inhibition of angiogenesis. However, while significant experimental data support the role of Maspin as a tumor suppressor, clinical data regarding the prognostic implications of Maspin expression have led to conflicting results. This highlights the need for a better understanding of the context dependencies of Maspin in normal biology and how these are perturbed in the context of cancer. In this review, we outline the regulation and roles of Maspin in normal and developmental biology while discussing novel evidence and emerging theories related to its functions in cancer. We provide insight into the immense therapeutic potential of Maspin and the challenges related to its successful clinical translation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10555-012-9361-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Growth differentiation factor 15 is a glucose-downregulated gene acting as the crosstalk between stroma and cancer cells of the human bladder.
Am J Physiol Cell Physiol
January 2025
Department of Anatomy, College of Medicine, Chang Gung University, Kwei-Shan, Taoyuan City 33302, Taiwan.
Hyperglycemia and hyperglycosuria, two primary characteristics of diabetes mellitus, may increase the risk of cancer initiation, particularly for bladder cancer. The effectiveness of metformin, a common antidiabetic agent, is determined by its ability to induce GDF15. However, the mechanism of the GDF15 in relation to glucose, which influences the tumor microenvironment in the human bladder, is not fully understood.
View Article and Find Full Text PDFOpposing Functions of Maspin Are Regulated by Its Subcellular Localization in Lung Squamous Cell Carcinoma Cells.
Cancers (Basel)
August 2024
Department of Pathology, Faculty of Medicine, Tottori University, Yonago 683-8505, Japan.
Mammary serine protease inhibitor (maspin) is a tumor suppressor protein downregulated during carcinogenesis and cancer progression; cytoplasmic-only maspin expression is an independent, unfavorable prognostic indicator in patients with lung squamous cell carcinoma (LUSC). We hypothesized that the cytoplasmic-only localization of maspin has tumor-promoting functions in LUSC. The subcellular localization of maspin and the invasive capability of LUSC cell lines were investigated using RNA sequencing (RNA-seq), Western blotting, and siRNA transfection.
View Article and Find Full Text PDFApplication of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides.
Clin Proteomics
August 2024
Department of Dermatology, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Dongcheng District, Beijing, 100730, China.
Article Synopsis
- Mycosis fungoides (MF) is a common skin lymphoma often misdiagnosed due to its non-specific early symptoms, leading to treatment delays; researchers aimed to find urinary biomarkers for early detection of MF through proteomic analysis.
- A study involving 13 early-stage MF patients treated with interferon α-2a and phototherapy analyzed urine samples before and after treatment, comparing them with healthy controls to identify differentially expressed proteins.
- The results revealed 41 proteins with significant expression changes, with certain proteins like Serpin B5, epidermal growth factor (EGF), and RhoA showing lower levels in untreated MF patients, but these levels normalized after treatment, indicating potential biomarkers for monitoring MF.
Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer.
Clin Transl Med
August 2024
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Positioning in 8q24.21 Involved in the Tumorigenesis of Colorectal Cancer by Targeting .
Protein Pept Lett
October 2024
Laboratory of Medical Genetics, Harbin Medical University, Harbin, China.
Background: Colorectal cancer remains to be the third leading cause of cancer mortality rates. Despite the diverse effects of the miRNA cluster located in of 8q24.21 across various tumors, the specific biological function in colorectal cancer has not been clarified.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!